Acquisition of data: Davis, Nunley, Kim, Hisey, Jackson, Bae, Hoffman, Gaede, Danielson, Gordon. Analysis and interpretation of data: Davis. Drafting the article: Davis. Critically revising the article: all authors. Reviewed submitted version of manuscript: all authors. Approved the final version of the manuscript on behalf of all authors: Davis.
Some results from this paper have been presented at the North American Spine Society Meeting in 2011, 2012, and 2013; International Society for Advancement of Spine Surgery Meeting in 2010 and 2013; Cervical Spine Research Society Meeting in 2011, 2012, and 2013; Eurospine in 2011; and AANS/CNS Joint Spine Section Meeting in 2011.
Davis RJKim KDHisey MSHoffman GABae HWGaede SE: Cervical total disc replacement with the Mobi-C cervical artificial disc compared with anterior discectomy and fusion for treatment of 2-level symptomatic degenerative disc disease: a prospective, randomized, controlled multi-center clinical trial. Clinical article. J Neurosurg Spine 19:532–5452013
Heller JGSasso RCPapadopoulos SMAnderson PAFessler RGHacker RJ: Comparison of BRYAN cervical disc arthroplasty with anterior cervical decompression and fusion: clinical and radiographic results of a randomized, controlled, clinical trial. Spine (Phila Pa 1976) 34:101–1072009
Murrey DJanssen MDelamarter RGoldstein JZigler JTay B: Results of the prospective, randomized, controlled multicenter Food and Drug Administration investigational device exemption study of the ProDisc-C total disc replacement versus anterior discectomy and fusion for the treatment of 1-level symptomatic cervical disc disease. Spine J 9:275–2862009
Phillips BBall CSackett DBadenoch DStraus SHaynes B: Oxford Centre for Evidence-Based Medicine – levels of evidence (March 2009). Centre for Evidence Based Medicine (http://www.cebm.net/oxford-centre-evidence-based-medicine-levels-evidence-march-2009/) [Accessed July 22 2014]
Zigler JEDelamarter RMurrey DSpivak JJanssen M: ProDisc-C and anterior cervical discectomy and fusion as surgical treatment for single-level cervical symptomatic degenerative disc disease: five-year results of a Food and Drug Administration study. Spine (Phila Pa 1976) 38:203–2092013